Anhui Xinguan vaccine emergency procurement results came out, three domestic inactivated vaccines are included in the use

Anhui Province pharmaceutical centralized procurement service center recently released documents show that three domestic inactivated vaccines are included in the use.
released documents show that Beijing Coxing Zhongwei Biotechnology Co., Ltd., Beijing Biological Products Research Institute Co., Ltd., Wuhan Biological Products Research Institute Co., Ltd. three companies produced the new crown inactivated vaccine are winning the bid, the price is 200 yuan / bottle or branch.
the relevant documents released this time show that China entered the third phase of clinical trials of the three inactivated vaccines are included in the emergency use.
Holdings Biotechnology Co., Ltd. is a Beijing-based bio-high-tech company, the first Chinese vaccine company listed in North America, currently listed on the NASDAQ Global Select Market.
owns four enterprises, Beijing Koxing Biological Products Co., Ltd., Koxing (Dalian) Vaccine Technology Co., Ltd., Beijing Coxing Zhongwei Biotechnology Co., Ltd. and Beijing Koxing Zhongyi Biopharmaceutical Co., Ltd., through its wholly-owned subsidiary, Koxing Holdings (Hong Kong) Co., Ltd.
has developed the world's first SARS coronavirus inactivated vaccine (completed phase I clinical studies), China's first pandemic influenza (H5N1) vaccine (Pharlef? and the world's first influenza A(H1N1) vaccine (Erlefu.1? )。
Institute of Biological Products Co., Ltd. (China Pharmaceuticals Research Institute of Biotechnology Co., Ltd.) is affiliated with the China Pharmaceutical Group, is the SASAC management of the central enterprise.
founded in 1919, is the cradle of Chinese biological products.
National Pharmaceutical Research Institute (Beijing Company) has a high-quality scientific research team, including Chinese Academy of Engineering academicians, the main business is vaccine research and development, is the research and development center of Chinese medicine, the company has more than 50 scientific research achievements have been awarded at the international, national and ministerial levels;
Wuhan Biological Products Research Institute Co., Ltd. ("Wuhan Biological Institute") was founded in September 1950, is now under the state-owned enterprises under the state's SASAC, China Pharmaceutical Group Co., Ltd., China Biotechnology Co., Ltd., is a biological products production, learning, research, marketing of large-scale high-tech Enterprises and one of the country's major biological products production base, is the central and southern region immunization planning guidance center, is the Ministry of Science and Technology awarded the National Joint Vaccine Engineering Technology Research Center, is the National Development and Reform Commission awarded the National Joint Engineering Research Center, shouldering the national health needs of biological products production, research and development and supply of the heavy responsibility.
Li Shaobai Source: Euro Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medical, and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here